Dr. Stephenson on 2 Years Following the Management of Localized Prostate Cancer
Andrew J. Stephenson, MD
Andrew J. Stephenson, MD, director for the Center of Urologic Oncology at the Cleveland Clinic, discusses the significance of a study investigating urinary, bowel, and sexual function at 2 years following the management of localized prostate cancer.
This is the first comparative study among 4 different treatments, explains Stephenson. This gives patients information regarding what to expect over the next 2 years with each treatment option.
According to Stephenson, it is important to balance the cancer control so as not to jeopardize a patient’s curability at the expense of quality of life.